Riskpilot← Back to searchSign inGet full accessDr Dag Strömberg AB
ABActiveOrg 5565672457Ryavägen 104General medical practice activities · NACE 8621Est. 19991 employees
Revenue 2025
SEK 898K
+37% vs 2024
EBITDA margin
65.0%
+49% vs 2024
Equity ratio
98.2%
Financial strength
Net profit 2025
SEK 482K
+38% vs 2024
| Revenue | SEK 898K | +37% |
| EBITDA | SEK 583K | +49% |
| Net profit | SEK 482K | +38% |
| Total assets | SEK 11,4M | +3% |
| Equity | SEK 11,2M | +3% |
| Employees | 1 | — |
Legal name
Dr Dag Strömberg AB
Org number
5565672457
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 mars 1999
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av Strömberg, Björn Dag Axel Strömberg, Pia Margareta
Company purpose
Aktiebolaget ska bedriva hälso- och sjukvård samt kapital- och fastighetsförvaltning samt bedriva därmed förenlig verksamhet.
Address
Ryavägen 104
Phone
+46707528866
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 549 | 656 | 898 |
| Staff expenses | — | — | — | −12 | −20 |
| EBITDA | −453 | −9 | 337 | 391 | 583 |
| Depreciation & amort. | −67 | −67 | −67 | −67 | −67 |
| EBIT | −520 | −76 | 270 | 323 | 516 |
| Net financials | 2 848 | 4 | −1 380 | 118 | 92 |
| Profit before tax | 2 328 | −72 | −361 | 441 | 608 |
| Tax | −0 | −0 | −22 | −91 | −125 |
| Net profit | 2 328 | −72 | −383 | 351 | 482 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 773 | 12 364 | 11 410 | 11 061 | 11 415 |
| Equity | 11 858 | 11 786 | 11 273 | 10 924 | 11 206 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 3 915 | 577 | 137 | 137 | 209 |
| Total debt | 3 915 | 577 | 137 | 137 | 209 |
EBITDA margin
65.0%
This company
15.8%
Market median
+311% vs market
20212025
Equity ratio
98.2%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20212025
Net profit margin
53.7%
This company
8.1%
Market median
+563% vs market
20212025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
HJ | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Dag Strömberg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Jonas Stefan Norell | Audit | 0 companies |
| Björn Dag Axel Strömberg | Board of Directors | 0 companies |
| Pia Margareta Strömberg | Deputy Board Member | 0 companies |